| Financial Year |
March 31 2023 |
| Monetary Funds |
1,091,576,287.06 |
| Held-for-trading Financial Assets |
487,844,252.32 |
| Notes Receivable |
-- |
| Accounts Receivable |
59,088,327.82 |
| Advances to Suppliers |
4,054,097.35 |
| Other Receivables |
24,959,834.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,370,694.44 |
| Dividend Receivable |
-- |
| Inventories |
195,669,991.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,876,157.68 |
| Total Current Assets |
1,901,984,310.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
57,045,575.43 |
| Investment Properties |
11,884,980.80 |
| Fixed Assetes |
237,046,486.14 |
| Under-construction Projects |
128,233.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,658,668.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,885,669.61 |
| Deferred Income Tax Assets |
16,993,228.40 |
| Other Non-Current Assets |
1,450,826.52 |
| Sub-Total of Non-Current Assets |
401,790,188.33 |
| Total Assets |
2,303,774,498.78 |
| Short-Term Loans |
80,000,000.00 |
| Trading Financial liabilities |
173,975.26 |
| Notes Payable |
13,900,000.00 |
| Accounts Payable |
24,377,099.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,288,690.00 |
| Taxes Payable |
3,076,783.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,642,850.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,261,360.10 |
| Other Current Liabilities |
1,357,605.98 |
| Sub-Total of Current Liabilities |
263,336,820.63 |
| Long-term Loans |
23,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
36,880,080.45 |
| Total Liabilities |
300,216,901.08 |
| Paid-In Capital(Or Share Stock) |
240,000,000.00 |
| Capital Surplus |
692,042,854.19 |
| Surplus Reserve |
104,092,201.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
968,501,959.36 |
| Minority Stockholder's Interest |
-660,205.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,004,217,803.56 |
| Owner's Equity（Stockholder's Equity） |
2,003,557,597.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,303,774,498.78 |
